BioCentury
ARTICLE | Clinical News

NuThrax regulatory update

June 20, 2011 7:00 AM UTC

FDA granted Fast Track designation for Emergent's NuThrax to prevent anthrax infection. The vaccine, which is being developed under FDA's Animal Rule, is in Phase Ib testing for the indication. FDA's ...